
Pathophysiological pathways in patients with heart failure and atrial fibrillation
Author(s) -
Bernadet T. Santema,
Vicente Artola Arita,
Iziah E Sama,
Mariëlle Kloosterman,
Maarten P. van den Berg,
Hans L A Nienhuis,
Isabelle C. Van Gelder,
Peter van der Meer,
Faı̈ez Zannad,
Marco Metra,
Jozine M. ter Maaten,
John G.F. Cleland,
Leong L. Ng,
Stefan D. Anker,
Chim C. Lang,
Nilesh J. Samani,
Kenneth Dickstein,
Gerasimos Filippatos,
Dirk J. van Veldhuisen,
Carolyn S.P. Lam,
Michiel Rienstra,
Adriaan A. Voors
Publication year - 2021
Publication title -
cardiovascular research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.774
H-Index - 219
eISSN - 1755-3245
pISSN - 0008-6363
DOI - 10.1093/cvr/cvab331
Subject(s) - medicine , atrial fibrillation , sinus rhythm , heart failure , cohort , biomarker , pathophysiology , cardiology , coronary artery disease , cohort study , endocrinology , biology , biochemistry
Atrial fibrillation (AF) and heart failure (HF) are two growing epidemics that frequently co-exist. We aimed to gain insights into the underlying pathophysiological pathways in HF patients with AF by comparing circulating biomarkers using pathway overrepresentation analyses.